1. Home
  2. AUDC vs IMMP Comparison

AUDC vs IMMP Comparison

Compare AUDC & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AudioCodes Ltd.

AUDC

AudioCodes Ltd.

N/A

Current Price

$10.96

Market Cap

247.7M

Sector

Utilities

ML Signal

N/A

Logo Immutep Limited

IMMP

Immutep Limited

N/A

Current Price

$4.56

Market Cap

42.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AUDC
IMMP
Founded
1992
1987
Country
Israel
Australia
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.7M
42.4M
IPO Year
2000
2012

Fundamental Metrics

Financial Performance
Metric
AUDC
IMMP
Price
$10.96
$4.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
87.5K
★ 330.4K
Earning Date
11-03-2026
10-06-2026
Dividend Yield
★ 3.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.05
N/A
Revenue Next Year
$3.87
N/A
P/E Ratio
$23.06
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.95
$0.26
52 Week High
$10.86
$5.36

Technical Indicators

Market Signals
Indicator
AUDC
IMMP
Relative Strength Index (RSI) 63.22 90.99
Support Level $8.14 $2.65
Resistance Level $10.86 N/A
Average True Range (ATR) 0.28 0.10
MACD 0.06 0.53
Stochastic Oscillator 90.98 84.52

Price Performance

Historical Comparison
AUDC
IMMP

About AUDC AudioCodes Ltd.

AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).

About IMMP Immutep Limited

Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: